No Detail Found!

Frequency of chemotherapy Induced Gait Deviations in Breast Cancer Female Survivors

Author(s)
Fatima Zahid Lahore College of Physical Therapy,Lahore,Pakistan
Hufsa Tariq Lahore University of Biological & Applied Sciences (UBAS),Lahore,Pakistan
Hafiz Muhammad Asim Lahore UBAS,Lahore,Pakistan
Abstract
Prolonged chemotherapy treatment in breast cancer patients can lead to the development of chemotherapy-induced peripheral neuropathy (CIPN). CIPN is a common adverse effect characterized by symptoms such as gait and balance impairments, as well as weakness in the lower extremities. These symptoms can significantly impact functional abilities and increase the risk of falls among patients. Importantly, these effects may persist even after completion of chemotherapy treatment, leading to long-term challenges in mobility and balance. O bjective : To determine the frequency of chemotherapy induced gait deviations in breast cancer female survivors. Methodology : Descriptive cross-sectional survey was conducted Data from 168 breast cancer survivors were collected from different cancer care hospitals in Lahore. Data collection was done by videotaping patient gait from multiple views and using JAKC Observational Gait Analysis. Results : Results via OGA scale showed deviations in ankle dorsiflexors 114 (67.9%) during mid-stance to terminal stance, inadequate extension of knee 86 (51.2%) during initial contact and inadequate flexion of thigh during initial contact 91(54.2%) and loading response 94 (56.0%). Conclusions : The results revealed gait deviations due to chemotherapy induced peripheral neuropathy in breast cancer survivors which results in slower gait velocity and can predict risk of fall. 
Publication Details
Page(s) 193-197
Published Journal: Journal Riphah College of Rehabilitation Sciences, Volume: 12, Issue: 4, Year: 2024

Request the full text from PASTIC

Keywords
OGA (Observational gait analysis), TUG (timed up and go)., BCS (breast cancer survivors) CIPN (chemotherapy induced peripheral neuropathy)
References
Hsieh KL,Wood TA,An R,Trinh L,Sosnoff JJ .2019 .Gait and balance impairments in breast cancer survivors: a systematic review and meta-analysis of observational studies. Arch Rehabil Res Clin Transl, 1(1) : 100001.
.1995 .Epidemiology of breast cancer. Eur J Cancer Prev, 4(1) : 7-30.
Shaukat U,Ismail M,Mehmood N M .2013 .Epidemiology, major risk factors and genetic predisposition for breast cancer in the Pakistani population. Asian Pac J Cancer Prev, 14(10) : 5625-9.
Hortobagyi GN .2000 .Developments in chemotherapy of breast cancer. Cancer, 88(S12) : 3073-9.
Hsieh KL,Trinh L,Sosnoff JJ .2019 .Gait variability is altered in cancer survivors with self-reported neuropathy. Gait Posture, 72 : 206-10.
Idrees R,Fatima S,Abdul-Ghafar J,Raheem A,Ahmad Z .2018 .Cancer prevalence in Pakistan: meta-analysis of various published studies to determine variation in cancer figures resulting from marked population heterogeneity in different parts of the country. World J Surg Oncol, 16(1) : 1.
Teran-Wodzinski P,Haladay D,Vu T,Ji M,Coury J,Adams A .2022 .Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial. Trials, 23(1) : 363.
Wechsler S,Wood L .2021 .The effect of chemotherapy on balance, gait, and falls among cancer survivors: a scoping review. Rehabil Oncol, 39(1) : 6-22.
Middleton A,Fritz SL,Lusardi M. .2015 .Walking speed: the functional vital sign. J Aging Phys Act, 23(2) : 314-22.
Winters-Stone KM,Dobek J,Bennett JA,Nail LM,Leo MC,Schwartz A .2012 .The effect of resistance training on muscle strength and physical function in older, postmenopausal breast cancer survivors: a randomized controlled trial. J Cancer Surviv, 6 : 189-99.
Imran A,Tariq H,Faisal S,Asim HM .2023 .Gait analysis among patients with quadriceps weakness after anterior cruciate ligament reconstruction post 9 months. Found Univ J Rehabil Sci, 3(2) : 58-65.
Hortobagyi GN,de la Garza Salazar J,Pritchard K,Amadori D,Haidinger R,Hudis CA .2005 .The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer, 6(5) : 391-401.
Alberti P,Salvalaggio A,Argyriou AA,Bruna J,Visentin A,Cavaletti G .2022 .Neurological complications of conventional and novel anticancer treatments. Cancers, 14(24) : 6088.
Cavaletti G,Cornblath DR,Merkies IS,Postma TJ,Rossi E,Alberti P .2019 .Patients' and physicians' interpretation of chemotherapy‐induced peripheral neurotoxicity. J Peripher Nerv Syst, 24(1) : 111-9.
Zahiri M,Chen KM,Zhou H,Nguyen H,Workeneh BT,Yellapragada SV .2019 .Using wearables to screen motor performance deterioration because of cancer and chemotherapy-induced peripheral neuropathy (CIPN) in adults-toward an early diagnosis of CIPN. J Geriatr Oncol, 10(6) : 960-7.
Kolb NA,Smith AG,Singleton JR,Beck SL,Stoddard GJ,Brown S .2016 .The association of chemotherapyinduced peripheral neuropathy symptoms and the risk of falling. JAMA Neurol, 73(7) : 860-6.
0

Citations

0

Downloads

85

Views